The Ivim Health Approach: GLP-1 ID for Individualized Results Understanding the differences between tirzepatide and semaglutide is just the beginning
The stronger correlation between changes in waist circumference and body weight in the semaglutide group compared with placebo suggests that weight loss induced by semaglutide preferentially targets visceral adipositybut this still accounts for only a minority of the cardiovascular protection
There are no brand name medicines that lower total medical cost over a population, and generally health economists believe that drugs that cost less than $100,000 or $150,000 per QALY are high value. Implications for employers: The net cost of GLP-1 drugs is already just 42% of the list price, so a 50% list price cut might not lead to employer savings
Sometimes the medication absorbs faster than expected
Choosing between tirzepatide and semaglutide depends on various factors, including personal health conditions, weight loss goals, and how the body responds to each medication